Tech Company Financing Transactions

Selexys Pharmaceuticals Funding Round

Selexys Pharmaceuticals closed a $2.8 million venture capital round on 4/20/2011. Backers included private investors.

Transaction Overview

Announced On
4/20/2011
Transaction Type
Debt
Amount
$2,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. Includes a $1,000,000 Overallotment Option exercisable in the sole discretion of Selexys. Although the offering period has ended, Selexys has retained the right to reopen the offering for up to 90 days in certain circumstances. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Research Parkway 510
Oklahoma City, OK 73104
USA
Email Address
Overview
Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that is developing drugs to treat inflammatory and thrombotic diseases.
Profile
Selexys Pharmaceuticals LinkedIn Company Profile
Social Media
Selexys Pharmaceuticals Company Twitter Account
Company News
Selexys Pharmaceuticals News
Facebook
Selexys Pharmaceuticals on Facebook
YouTube
Selexys Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Rollins
  Scott Rollins LinkedIn Profile  Scott Rollins Twitter Account  Scott Rollins News  Scott Rollins on Facebook
Chief Medical Officer
Rodger McEver
  Rodger McEver LinkedIn Profile  Rodger McEver Twitter Account  Rodger McEver News  Rodger McEver on Facebook
Chief Scientific Officer
Richard Cummings
  Richard Cummings LinkedIn Profile  Richard Cummings Twitter Account  Richard Cummings News  Richard Cummings on Facebook
VP - Bus. Development
David Falconer
  David Falconer LinkedIn Profile  David Falconer Twitter Account  David Falconer News  David Falconer on Facebook
VP - Operations
Richard Alvarez
  Richard Alvarez LinkedIn Profile  Richard Alvarez Twitter Account  Richard Alvarez News  Richard Alvarez on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/20/2011: bluebird bio venture capital transaction
Next: 4/20/2011: ex.fm venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary